As a result of the entry into force of Regulation (EU) 2019/989 of 17 June 2019 concerning the non-renewal of chlorpropham approval, ANSES has withdrawn 22 […]
As a result of the entry into force of Regulation (EU) 2019/677 of 29th April 2019 concerning the non-renewal of chlorothalonil approval, ANSES withdraw 25 authorisations […]
In Anses Opinion dated 19 April 2019, Anses concluded that Epoxiconazole is an endocrine disruptor for humans and non-target organisms. Further to this evaluation, Anses has […]